Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 18 Breast Neoplasms 17 Advanced Solid Tumors 16 Advanced Solid Tumor 12 Carcinoma, Non-Small-Cell Lung 10 Myelodysplastic Syndromes 8 Solid Tumor 6 Recurrence 6 Prostatic Neoplasms 6 Lymphoma, Large B-Cell, Diffuse 6 Uterine Cervical Neoplasms 5 Triple Negative Breast Neoplasms 5 Stomach Neoplasms 5 Ovarian Neoplasms 5 Carcinoma, Hepatocellular 5 Small Cell Lung Carcinoma 4 Myeloproliferative Disorders 4 Multiple Myeloma 4 Advanced Solid Tumour 4 Advanced Malignant Solid Tumor 4 Solid Tumors 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasms 3 Lymphoma, Non-Hodgkin 3 Lymphoma 3 Leukemia, Myelomonocytic, Chronic 3 Biliary Tract Neoplasms 3 Advanced Lung Cancer 3 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2

Interventions

Gemcitabine 2 toripalimab 1 surufatinib 1 Paclitaxel 1 Injections 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Pancreatic Cancer Metastatic × Injections × Clear all

NCT06752811 2026-02-10

pompom

Shanghai Yizhong Pharmaceutical Co., Ltd.

Phase 3 Recruiting

Gastrointestinal

Pancreatic Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡